BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34309912)

  • 1. Efficacy of bath-psoralen and ultraviolet A therapy for mycosis fungoides - retrospective analysis of 62 cases.
    Shintani Y; Nishida E; Furuhashi T; Muramatsu S; Kubo R; Nakamura M; Watanabe S; Masuda H; Ikumi K; Matsumoto K; Yamazaki S; Morita A
    J Dermatol; 2022 Feb; 49(2):239-245. PubMed ID: 34309912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combined therapy of psoralen plus ultraviolet A followed by narrow band ultraviolet B photochemotherapy for early stage mycosis fungoides].
    Wang T; Liu Y; Zheng H; Zuo Y; Fang K
    Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):626-8. PubMed ID: 25430032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis.
    Phan K; Ramachandran V; Fassihi H; Sebaratnam DF
    JAMA Dermatol; 2019 Mar; 155(3):335-341. PubMed ID: 30698622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of bath psoralen plus ultraviolet A in early-stage mycosis fungoides.
    Pavlotsky F; Hodak E; Ben Amitay D; Barzilai A
    J Am Acad Dermatol; 2014 Sep; 71(3):536-41. PubMed ID: 24836546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
    Weber F; Schmuth M; Sepp N; Fritsch P
    Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Early Folliculotropic Mycosis Fungoides with Special Focus on Psoralen plus Ultraviolet A.
    Amitay-Laish I; Prag-Naveh H; Dalal A; Pavlovsky L; Feinmesser M; Hodak E
    Acta Derm Venereol; 2018 Nov; 98(10):951-955. PubMed ID: 30085321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Low-Dose, Low-Frequency Oral Psoralen-UV-A Treatment With or Without Maintenance on Early-Stage Mycosis Fungoides: A Randomized Clinical Trial.
    Vieyra-Garcia P; Fink-Puches R; Porkert S; Lang R; Pöchlauer S; Ratzinger G; Tanew A; Selhofer S; Paul-Gunther S; Hofer A; Gruber-Wackernagel A; Legat F; Patra V; Quehenberger F; Cerroni L; Clark R; Wolf P
    JAMA Dermatol; 2019 May; 155(5):538-547. PubMed ID: 30892603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chart review of patients with early stage mycosis fungoides treated with psoralen plus UVA (PUVA).
    Soung J; Muigai W; Amin N; Stern DK; Lebwohl MG
    J Drugs Dermatol; 2005; 4(3):290-4. PubMed ID: 15898283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
    Ahmad K; Rogers S; McNicholas PD; Collins P
    Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto.
    Almohideb M; Walsh S; Walsh S; Shear N; Alhusayen R
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):604-612. PubMed ID: 28711574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
    Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
    Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides.
    Ponte P; Serrão V; Apetato M
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):716-21. PubMed ID: 19929938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phototherapy for mycosis fungoides.
    Dogra S; Mahajan R
    Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of stage Ia and Ib mycosis fungoides with psoralen UVA monotherapy: an observational study in tertiary hospitals in the Canary Islands.
    Hernández Z; Peñate Y; Hernández-Machín B; Pérez-Méndez L; Suárez-Hernández J; Hernández J; Fernández-de-Misa R
    Int J Dermatol; 2014 Nov; 53(11):1417-22. PubMed ID: 24697305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study.
    Diederen PV; van Weelden H; Sanders CJ; Toonstra J; van Vloten WA
    J Am Acad Dermatol; 2003 Feb; 48(2):215-9. PubMed ID: 12582391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of parapsoriasis and mycosis fungoides: the role of psoralen and long-wave ultraviolet light A (PUVA).
    Powell FC; Spiegel GT; Muller SA
    Mayo Clin Proc; 1984 Aug; 59(8):538-46. PubMed ID: 6748744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photochemotherapy (PUVA) in the tumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
    Molin L; Thomsen K; Volden G; Groth O
    Acta Derm Venereol; 1981; 61(1):52-4. PubMed ID: 6164215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folliculotropic mycosis fungoides in a pediatric patient with response to psoralen-ultraviolet A phototherapy.
    Boix-Vilanova J; Corral-Magaña O; Martin-Santiago A; Escalas J
    Photodermatol Photoimmunol Photomed; 2019 Jan; 35(1):54-56. PubMed ID: 30007081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early-stage mycosis fungoides: a right-left comparative study.
    El-Mofty M; El-Darouty M; Salonas M; Bosseila M; Sobeih S; Leheta T; Nada H; Tawdy A; Amin I; El-Enany G
    Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):281-6. PubMed ID: 16313238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
    Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
    Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.